Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

447 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Modafinil for the Treatment of Fatigue in Lung Cancer V9.0

NCT00829322

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Stoke Mandeville Hospital Aylesbury, United Kingdom
  • Macclesfield District Hospital Cheshire, United Kingdom
  • University Hospital of North Tees County Durham, United Kingdom
  • Basildon and Thurrock University Hospitals Essex, United Kingdom
View all 24 locations
View Trial Details
Completed

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

NCT00092924

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Rush Medical College Chicago, Illinois, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab

NCT00536640

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Klinikum Bayreuth GmbH Bayreuth, Germany
  • Charite´ Mitte Berlin, Germany
  • Gemeinschaftskrankenhaus Havelhöhe Berlin, Germany
  • Helios Klinikum Emil v. Behring Berlin, Germany
View all 37 locations
View Trial Details
Completed

A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone

NCT00265317

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Antioch, California, United States
View all 32 locations
View Trial Details
Completed

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

NCT00622349

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium
  • Pneumology department of CHU Lille Lille, France
  • Hellenic Cancer Institute - St Savas Oncology Hospital Athens, Greece
  • Medical Oncology Hospital de Sagunto Valencia, Spain
View Trial Details

Related conditions